| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Revenue | $75K | +2.7% |
| R&D Expense | $12.8M | +13.3% |
| SG&A Expense | $6.4M | -4.0% |
| Operating Income | -$19.1M | -6.9% |
| Net Income | -$19.6M | -7.4% |
| EPS (Basic) | -$14.12 | -533.2% |
| EPS (Diluted) | -$14.12 | -533.2% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.5M | -39.0% |
| Accounts Receivable | $55K | +1733.3% |
| Current Assets | $3.7M | -22.6% |
| Total Assets | $4.5M | -25.3% |
| Current Liabilities | $4.0M | +57.1% |
| Total Liabilities | $4.3M | +37.9% |
| Stockholders' Equity | $202K | -93.0% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.0M | -13.3% |
| Capital Expenditures | $1K | -92.3% |
| Investing Cash Flow | -$1K | +92.3% |
| Financing Cash Flow | $16.0M | — |
| Free Cash Flow | -$18.0M | -13.2% |